Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear speckle splicing regulatory protein 1 pseudogene 1 (NSRP1P1) is a human pseudogene, originally derived from the gene encoding nuclear speckle splicing regulatory protein 1. Unlike its protein-coding ancestor, NSRP1P1 has lost protein-coding potential—either through sequence changes such as premature stop codons or deletions—and does not yield a functional protein[1][5]. It is cataloged as a "pseudogene" and does not fulfill the criteria of a receptor, enzyme, transporter, or other classic therapeutic target. There are no direct reports of the pseudogene being druggable, involved in disease pathways, or serving as a clinical biomarker. While some pseudogenes are known to influence the expression of related genes through non-coding RNA mechanisms, such a role has not yet been established for NSRP1P1 and would require additional validation[2][3][6]. In summary, NSRP1P1 is not a therapeutic target, is a pseudogene, and there are no known biological, disease, or therapeutic roles specific to it. Most entries requested should be returned as null except for its name, aliases, and pseudogene classification.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear speckle splicing regulatory protein 1 pseudogene 1 (NSRP1P1).